• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有与炎症性肠病相关的眼部疾病的患者后续诊断为炎症性肠病的风险:来自英国初级保健数据的回顾性队列分析。

Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data.

机构信息

Gastroenterology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.

Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

出版信息

BMJ Open. 2022 May 11;12(5):e052833. doi: 10.1136/bmjopen-2021-052833.

DOI:10.1136/bmjopen-2021-052833
PMID:35545379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9096531/
Abstract

OBJECTIVES

Ophthalmic conditions including anterior uveitis (AU), episcleritis and scleritis may occur in association with the inflammatory bowel diseases (IBD) as ophthalmic extraintestinal manifestations. The aim of this study was to assess the risk of a later IBD diagnosis in those presenting with IBD associated ocular inflammation (IAOI).

DESIGN

Retrospective cohort study.

SETTING

Primary care UK database.

PARTICIPANTS

38 805 subjects with an IAOI were identified (median age 51 (38-65), 57% women) and matched to 153 018 subjects without IAOI.

MEASURES

The risk of a subsequent diagnosis of IBD in subjects with IAOIs compared with age/sex matched subjects without IAOI. HRs were adjusted for age, sex, body mass index, deprivation, comorbidity, smoking, baseline axial arthropathy, diarrhoea, loperamide prescription, anaemia, lower gastrointestinal bleeding and abdominal pain.Logistic regression was used to produce a prediction model for a diagnosis of IBD within 3 years of an AU diagnosis.

RESULTS

213 (0.6%) subsequent IBD diagnoses (102 ulcerative colitis (UC) and 111 Crohn's disease (CD)) were recorded in those with IAOIs and 329 (0.2%) (215 UC and 114 CD) in those without. Median time to IBD diagnosis was 882 (IQR 365-2043) days in those with IAOI and 1403 (IQR 623-2516) in those without. The adjusted HR for a subsequent diagnosis of IBD was 2.25 (95% CI 1.89 to 2.68), p<0.001; for UC 1.65 (95% CI 1.30 to 2.09), p<0.001; and for CD 3.37 (95% CI 2.59 to 4.40), p<0.001 in subjects with IAOI compared with those without.Within 3 years of an AU diagnosis, 84 (0.5%) subjects had a recorded diagnosis of IBD. The prediction model performed well with a C-statistic of 0.75 (95% CI 0.69 to 0.80).

CONCLUSIONS

Subjects with IAOI have a twofold increased risk of a subsequent IBD diagnosis. Healthcare professionals should be alert for potential signs and symptoms of IBD in those presenting with ophthalmic conditions associated with IBD.

摘要

目的

眼部疾病包括前葡萄膜炎(AU)、表层巩膜炎和巩膜炎可能与炎症性肠病(IBD)同时发生,作为眼部肠外表现。本研究旨在评估那些伴有 IBD 相关眼部炎症(IAOI)的患者发生 IBD 后诊断的风险。

设计

回顾性队列研究。

设置

英国初级保健数据库。

参与者

确定了 38805 例 IAOI 患者(中位年龄 51(38-65)岁,57%为女性),并与 153018 例无 IAOI 的患者相匹配。

措施

与无 IAOI 的年龄/性别匹配患者相比,IAOI 患者发生 IBD 后诊断的风险。使用 HR 调整了年龄、性别、体重指数、贫困程度、合并症、吸烟、基线轴向关节炎、腹泻、洛哌丁胺处方、贫血、下消化道出血和腹痛。使用逻辑回归为 AU 诊断后 3 年内的 IBD 诊断生成预测模型。

结果

在 IAOI 患者中记录了 213 例(0.6%)后续 IBD 诊断(102 例溃疡性结肠炎(UC)和 111 例克罗恩病(CD)),在无 IAOI 患者中记录了 329 例(0.2%)(215 例 UC 和 114 例 CD)。IAOI 患者的中位 IBD 诊断时间为 882(IQR 365-2043)天,无 IAOI 患者为 1403(IQR 623-2516)天。IAOI 患者后续诊断为 IBD 的调整 HR 为 2.25(95%CI 1.89-2.68),p<0.001;UC 为 1.65(95%CI 1.30-2.09),p<0.001;CD 为 3.37(95%CI 2.59-4.40),p<0.001。与无 IAOI 的患者相比,IAOI 患者的风险更高。在 AU 诊断后 3 年内,84(0.5%)例患者有记录的 IBD 诊断。预测模型的 C 统计量为 0.75(95%CI 0.69-0.80),表现良好。

结论

IAOI 患者发生 IBD 的风险增加一倍。医疗保健专业人员应警惕那些患有与 IBD 相关的眼部疾病的患者出现潜在的 IBD 症状和体征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a63/9096531/fcce3fdc1edc/bmjopen-2021-052833f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a63/9096531/f093d834ea33/bmjopen-2021-052833f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a63/9096531/b18176b1f595/bmjopen-2021-052833f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a63/9096531/fcce3fdc1edc/bmjopen-2021-052833f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a63/9096531/f093d834ea33/bmjopen-2021-052833f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a63/9096531/b18176b1f595/bmjopen-2021-052833f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8a63/9096531/fcce3fdc1edc/bmjopen-2021-052833f03.jpg

相似文献

1
Risk of a subsequent diagnosis of inflammatory bowel disease in subjects with ophthalmic disorders associated with inflammatory bowel disease: a retrospective cohort analysis of UK primary care data.患有与炎症性肠病相关的眼部疾病的患者后续诊断为炎症性肠病的风险:来自英国初级保健数据的回顾性队列分析。
BMJ Open. 2022 May 11;12(5):e052833. doi: 10.1136/bmjopen-2021-052833.
2
The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.与炎症性肠病相关的皮肤病患者中炎症性肠病延迟诊断的风险
Inflamm Bowel Dis. 2021 Oct 20;27(11):1731-1739. doi: 10.1093/ibd/izaa344.
3
Development and validation of a risk prediction tool for the diagnosis of inflammatory bowel disease in patients presenting in primary care with abdominal symptoms.用于诊断初级保健中出现腹部症状患者炎症性肠病的风险预测工具的开发与验证
J Crohns Colitis. 2025 Apr 4;19(4). doi: 10.1093/ecco-jcc/jjaf044.
4
The Time to Inflammatory Bowel Disease Diagnosis for Patients Presenting with Abdominal Symptoms in Primary Care and its Association with Emergency Hospital Admissions and Surgery: A Retrospective Cohort Study.基层医疗中出现腹部症状的炎症性肠病患者的诊断时间及其与急诊入院和手术的关联:一项回顾性队列研究
Inflamm Bowel Dis. 2025 Jan 6;31(1):140-150. doi: 10.1093/ibd/izae057.
5
Risk of Inflammatory Bowel Disease in Patients With Atopic Dermatitis.特应性皮炎患者发生炎症性肠病的风险。
JAMA Dermatol. 2023 Oct 1;159(10):1085-1092. doi: 10.1001/jamadermatol.2023.2875.
6
Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study.炎症性肠病患者的痴呆风险:一项丹麦基于人群的研究。
Aliment Pharmacol Ther. 2022 Sep;56(5):831-843. doi: 10.1111/apt.17119. Epub 2022 Jul 3.
7
The Risk of Inflammatory Bowel Disease in Subjects Presenting With Perianal Abscess: Findings From the THIN Database.患有肛周脓肿的患者发生炎症性肠病的风险:来自 THIN 数据库的研究结果。
J Crohns Colitis. 2019 Apr 26;13(5):600-606. doi: 10.1093/ecco-jcc/jjy210.
8
Risk Factors for the Occurrence and Severity of Vertebral Fractures in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Cohort Study.炎症性肠病患者椎体骨折发生和严重程度的危险因素:一项全国基于人群的队列研究。
J Korean Med Sci. 2023 Jul 17;38(28):e210. doi: 10.3346/jkms.2023.38.e210.
9
Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study.葡萄膜炎患者炎症性肠病的风险:基于人群的队列研究。
Eye (Lond). 2022 Jun;36(6):1288-1293. doi: 10.1038/s41433-021-01645-4. Epub 2021 Jun 21.
10
The causal impact of genetically predicted inflammatory bowel disease on extraintestinal manifestations: a mendelian randomization study.基因预测的炎症性肠病对肠外表现的因果影响:一项孟德尔随机化研究。
BMC Gastroenterol. 2025 Mar 4;25(1):135. doi: 10.1186/s12876-024-03566-4.

引用本文的文献

1
Ocular Manifestations of IBD: Pathophysiology, Epidemiology, and Iatrogenic Associations of Emerging Treatment Strategies.炎症性肠病的眼部表现:新兴治疗策略的病理生理学、流行病学及医源性关联
Biomedicines. 2024 Dec 16;12(12):2856. doi: 10.3390/biomedicines12122856.
2
Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review.炎症性肠病患者眼部肠外表现发病率的分析:一项系统评价
Diagnostics (Basel). 2024 Dec 14;14(24):2815. doi: 10.3390/diagnostics14242815.
3
Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development Program.

本文引用的文献

1
Epidemiology and Clinical Characteristics of Episcleritis and Scleritis in Olmsted County, Minnesota.明尼苏达州奥姆斯特德县的表层巩膜炎和巩膜炎的流行病学和临床特征。
Am J Ophthalmol. 2020 Sep;217:317-324. doi: 10.1016/j.ajo.2020.04.043. Epub 2020 May 11.
2
Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.英国炎症性肠病的流行病学和结局变化模式:2000-2018 年。
Aliment Pharmacol Ther. 2020 May;51(10):922-934. doi: 10.1111/apt.15701. Epub 2020 Apr 1.
3
Inflammatory bowel disease: Looking beyond the tract.
在etrasimod研发项目中黄斑水肿及其他眼部事件的低发生率
J Crohns Colitis. 2025 May 8;19(5). doi: 10.1093/ecco-jcc/jjae173.
4
Identifying TNF and IL6 as potential hub genes and targeted drugs associated with scleritis: A bio-informative report.鉴定 TNF 和 IL6 作为与巩膜炎相关的潜在枢纽基因和靶向药物:生物信息学报告。
Front Immunol. 2023 Mar 31;14:1098140. doi: 10.3389/fimmu.2023.1098140. eCollection 2023.
5
A Review of Ophthalmic Complications in Inflammatory Bowel Diseases.炎症性肠病的眼科并发症综述
J Clin Med. 2022 Dec 15;11(24):7457. doi: 10.3390/jcm11247457.
6
The Prevalence of Ocular Extra-Intestinal Manifestations in Adults Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.成人炎症性肠病眼部肠外表现的患病率:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Nov 25;19(23):15683. doi: 10.3390/ijerph192315683.
炎症性肠病:超越肠道的视野。
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419866567. doi: 10.1177/2058738419866567.
4
IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology.苏格兰洛锡安区基于捕捉-再捕获法推算的 IBD 患病率。
Gut. 2019 Nov;68(11):1953-1960. doi: 10.1136/gutjnl-2019-318936. Epub 2019 Jul 11.
5
Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis.炎症性肠病的肠外表现——流行病学、遗传学和发病机制。
Expert Rev Gastroenterol Hepatol. 2019 Apr;13(4):307-317. doi: 10.1080/17474124.2019.1574569. Epub 2019 Feb 20.
6
Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.韩国炎症性肠病患者的肠外表现患病率。
PLoS One. 2018 Jul 10;13(7):e0200363. doi: 10.1371/journal.pone.0200363. eCollection 2018.
7
Ocular Manifestations of Paediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.儿科炎症性肠病的眼部表现:系统评价和荟萃分析。
J Crohns Colitis. 2018 Jun 28;12(7):870-879. doi: 10.1093/ecco-jcc/jjy029.
8
Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.银屑病关节炎患者发生葡萄膜炎和炎症性肠病的风险:一项基于人群的队列研究。
Ann Rheum Dis. 2018 Feb;77(2):277-280. doi: 10.1136/annrheumdis-2017-212328. Epub 2017 Nov 1.
9
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率:基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
10
Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.炎症性肠病患者自身免疫性和炎症性疾病的风险增加。
World J Gastroenterol. 2017 Sep 7;23(33):6137-6146. doi: 10.3748/wjg.v23.i33.6137.